Treatment of Acute Pericarditis
The first-line treatment for acute pericarditis is combination therapy with aspirin or NSAIDs plus colchicine, both given together from the start, with gastroprotection mandatory. This dual-drug approach is a Class I, Level A recommendation that significantly reduces recurrence rates and improves outcomes 1.
First-Line Therapy: Dual Anti-Inflammatory Approach
The cornerstone of treatment involves starting both medications simultaneously:
NSAIDs or Aspirin
- Aspirin: 750-1000 mg every 8 hours
- Ibuprofen: 600 mg every 8 hours (preferred NSAID)
- Duration: 1-2 weeks for uncomplicated cases, guided by symptoms and CRP normalization
- Always provide gastroprotection (proton pump inhibitor)
- Taper gradually: decrease aspirin by 250-500 mg every 1-2 weeks; ibuprofen by 200-400 mg every 1-2 weeks 1
Colchicine (Mandatory Addition)
- Weight-based dosing: 0.5 mg once daily if <70 kg; 0.5 mg twice daily if ≥70 kg
- Duration: 3 months minimum for acute pericarditis
- No loading dose required
- Tapering not mandatory but can use 0.5 mg every other day in final weeks 1
Critical point: Colchicine reduces recurrence risk from 30-37.5% to approximately 15-17% 2, 3. Without colchicine, you're accepting a doubled recurrence rate—this is unacceptable given the drug's safety profile and strong evidence base.
Monitoring Treatment Response
Use C-reactive protein (CRP) as your objective guide 1:
- Check CRP at baseline and serially during treatment
- Continue therapy until CRP normalizes
- Only begin tapering once symptoms resolve AND CRP normalizes
- If CRP remains elevated or symptoms persist, this signals treatment failure requiring escalation
When First-Line Therapy Fails
If inadequate response to NSAIDs plus colchicine after appropriate duration:
Second-Line: Low-Dose Corticosteroids
- Prednisone 0.2-0.5 mg/kg/day (NOT high-dose 1.0 mg/kg/day)
- Use as triple therapy (add to NSAIDs and colchicine, don't replace them) 1
- Critical caveat: Corticosteroids promote chronicity, increase recurrence rates, and cause drug dependence 1
- Must exclude bacterial infection (especially tuberculosis) before starting 1
- Taper extremely slowly—critical threshold is 10-15 mg/day prednisone where recurrences spike; use 1.0-2.5 mg decrements every 2-6 weeks at this level 1
Specific Indications for Corticosteroids as Second-Line:
- True NSAID allergy
- Recent peptic ulcer or GI bleeding
- High bleeding risk on anticoagulation
- Pregnancy beyond 20 weeks
- Autoimmune/systemic inflammatory disease
- Post-pericardiotomy syndrome 1, 4
Third-Line: IL-1 Inhibitors
For recurrent pericarditis refractory to conventional therapy:
- Anakinra or rilonacept (10% recurrence vs 78% with placebo, RR 0.14) 3
- Preferred over prolonged corticosteroids in multiply recurrent cases 5, 2
- Reserve for patients with multiple recurrences over several years
Activity Restriction
Non-athletes: Restrict exercise until symptoms resolve AND CRP, ECG, and echocardiogram normalize 1
Athletes: Minimum 3-month restriction from competitive sports after symptom onset, even if tests normalize earlier 1
Common Pitfalls to Avoid
Starting corticosteroids first-line: This is explicitly NOT recommended (Class III) 1. Corticosteroids as initial therapy increase recurrence rates to 50% and promote chronic disease.
Omitting colchicine: Without colchicine, 30% will develop recurrent disease; with it, only 15% recur 1. This is preventable morbidity.
Inadequate treatment duration: Stopping NSAIDs before CRP normalizes or using colchicine for <3 months leads to recurrence 1.
Rapid corticosteroid taper: If corticosteroids are used, tapering too quickly (especially through the 10-15 mg/day threshold) triggers recurrence 1.
Tapering multiple drugs simultaneously: When achieving remission, taper one drug class at a time before discontinuing colchicine last 1.
Ignoring CRP: This is your objective marker—symptoms alone are insufficient to guide therapy duration 1.
Recurrent Pericarditis Protocol
For first recurrence: